Hogan Lovells International LLP
Hogan Lovells International LLP‘s team has ’excellent‘ expertise across a wide variety of areas, including orphan designations, pharma advertising, and supply chain structures. Practice head Hein van den Bos is well known for his IP and technology expertise, which he utilises to advise international pharma and biotech companies on EU marketing authorisation applications and disputes concerning data exclusivity. Bert Oosting is particularly skilled at handling international patent disputes before the European Patent Office (EPO), while Karen Jelsma assists clients with regulatory issues, including clinical trial agreements and distribution disputes. The ’exceptionally intelligent‘ Gertjan Kuipers is a ’sharp and gifted‘ litigator who primarily focuses on patent infringement cases.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘I would follow Gertjan Kuipers anywhere!
- ‘Gertjan Kuipers is exceptionally intelligent and he is a sharp and gifted litigator. He will quickly learn any technology that is the subject of a litigation, and understands the big picture.’
‘Global scope, nice down-to-earth people and excellent expertise.’
‘Hein van de Bos and Karen Jelsma are both practical and nice people with excellent expertise.’
Key clients
- Ferring
Work highlights
- Assisted a US-based pharmaceutical company with its first marketing authorisation application before the European Medicines Agency for a remedy for a serious disease for which there are currently limited treatment options.
- Conducted a European Medicines Agency and Dutch authority mock inspection regarding compliance with EU pharmacovigilance requirements.
- Represented BMS in various patent proceedings relating to BMS’ product Eliquis® (apixaban).
Lawyers
Leading individuals
Practice head
The lawyer(s) leading their teams.
Hein van den Bos